More on ORIC

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.4 Score)

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

ORIC Pharmaceuticals Inc. (NQ:ORIC)
Delayed: 10.73 --0 (-0%)
Prev. Close $10.73  
Open$10.55 
52 Wk High$ 
52 Wk Low$ 
Day High$11.00 
Day Low$10.41 
P/E N/A  
EPS$ 
Volume1,666,700 

Friends, Peers and Foes (?): ARWR, CELC, KALV TVTX (more...)

Jul 14, 2026 04:05 PM ORIC Pharmaceuticals starts Phase 3 trial for prostate cancer drug
Jul 14, 2026 04:05 PM ORIC® Pharmaceuticals Announces Initiation of Himalayas-1 Phase 3 Trial in mCRPC Evaluating Rinzimetostat in Combination with NUBEQA® (Darolutamide), Supported by Clinical Collaboration with Bayer
Jul 8, 2026 04:35 PM Form 4 Oric Pharmaceuticals, For: Jul 06 Filed by: Heyman Richard A.
Jul 6, 2026 04:28 PM Form 144 Oric Pharmaceuticals, Filed by: Heyman Richard A.
Jul 6, 2026 04:27 PM Form 144 Oric Pharmaceuticals, Filed by: Heyman Richard A.
Jul 2, 2026 04:30 PM ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Jun 22, 2026 04:05 PM Form 8-K Oric Pharmaceuticals, For: Jun 18
Jun 11, 2026 04:07 PM Stifel Starts ORIC Pharmaceuticals (ORIC) at Buy
Jun 8, 2026 06:57 AM H.C. Wainwright Reiterates Buy Rating on ORIC Pharmaceuticals (ORIC)
Jun 5, 2026 04:30 PM ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
View All Articles

Entities mentioned with ORIC

View All Entities